Seagen po­si­tions Tukysa com­bo as op­tion for breast can­cer pa­tients with brain metas­tases

Last year
R&D

Ger­man biotech’s ef­forts to re­vive obe­si­ty tar­get for sol­id tu­mors yield pos­i­tive PhI­Ia re­sults

Last year
R&D

Aviv Regev leads Genen­tech's next rev­o­lu­tion with AI

Last year
R&D
AI

Phar­varis soars on mid-stage da­ta for se­vere swelling con­di­tion, rais­es $300M

Last year
Financing
R&D

FDA ap­proves No­var­tis drug for rare blood dis­or­der

Last year
Pharma
FDA+

IGM Bio­sciences cuts 22% of work­force, ax­es hema­to­log­ic on­col­o­gy pro­gram

Last year
People
R&D

Mer­ck KGaA’s evo­bru­ti­nib dis­ap­points in PhI­II mul­ti­ple scle­ro­sis test, cast­ing dark cloud over BTK class

Last year
R&D

Up­dat­ed: Will the UK’s triple-pronged ap­proach ease pric­ing, reg­u­la­to­ry and fi­nan­cial bot­tle­necks?

Last year
Pharma
In Focus

J&J note­book: High­lights from a day of pipeline and strat­e­gy dis­cus­sion

Last year
R&D
Pharma

FDA sends let­ter to No­var­tis over Kym­ri­ah man­u­fac­tur­ing safe­ty con­cerns

Last year
Pharma
FDA+

The pol­i­tics be­hind drug short­ages: Sen­a­tors talk is­sues with gener­ics mar­ket, CMS pay­ments

Last year
Pharma
FDA+

Sen. Bill Cas­sidy plots a path for more com­mer­cial­ly vi­able cell and gene ther­a­pies

Last year
Pharma
Cell/Gene Tx

As­traZeneca says CMS guid­ance around IRA ex­emp­tions is 'un­law­ful' in lat­est court brief

Last year
Pharma
Law

Scoop: Res­o­nance Med­i­cine, a pro­tease biotech from David Liu’s lab, shuts down

Last year
People
Startups

Mar­ket­ingRx roundup: Phar­mas dou­ble down on re­new­able en­er­gy; Bay­er funds health eq­ui­ty re­search

Last year
Pharma
Marketing

CVS Health joins in on a new way for phar­ma­cies to get paid for pre­scrip­tion drugs

Last year
Health Tech

Bio­gen col­lab­o­ra­tor Neu­roSense shares sec­ondary PhI­Ib da­ta for its ALS treat­ment

Last year
R&D

Ab­b­Vie’s new AI deal; Roche's PhI­II win in breast can­cer; Spring­Works to raise $275M

Last year
News Briefing

Obe­si­ty deals come in­to fo­cus af­ter Roche shells out $2.7B for Car­mot

Last year
Deals
Pharma

Scoop: In­fec­tious dis­ease biotech eyes $25M Se­ries A to ad­vance an­ti­body for chron­ic lung in­fec­tion

Last year
Financing
R&D

Bausch Health’s Sal­ix ini­ti­ates first aware­ness day for opi­oid-in­duced con­sti­pa­tion

Last year
Pharma
Marketing

Boehringer looks 'be­yond sta­ble' to dis­play the every­day re­al­i­ties of life with schiz­o­phre­nia

Last year
Pharma
Marketing

BIO names its vice chair and Am­i­cus founder John Crow­ley as next CEO

Last year
People

Lil­ly’s Verzenio just miss­es the mark on over­all sur­vival in PhI­II breast can­cer study

Last year
R&D
First page Previous page 235236237238239240241 Next page Last page
A service from the Financial Times